ENHANCE Study Had Impact on Ezetimibe New Users, StoppagesENHANCE Study Had Impact on Ezetimibe New Users, Stoppages

Three years after the negative ENHANCE trial with ezetimibe, nearly 2% of patients enrolled in a large pharmacy plan were still taking the medication. New users were down, though, and discontinuations were up. Heartwire

Source: Medscape Today Headlines - August 1, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news